Norden Group’s Eli Lilly LLY Stock Holding History

Norden Group’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.66M	Buy	9,417 +252	+3%	+$255K	0.83%	22
2025 Q4	$9.85M	Buy	9,165 +313	+4%	+$299K	0.96%	16
2025 Q3	$6.75M	Buy	8,852 +83	+0.9%	+$61.8K	0.69%	31
2025 Q2	$6.84M	Buy	8,769 +59	+0.7%	+$45.8K	0.74%	22
2025 Q1	$7.19M	Buy	8,710 +1,717	+25%	+$1.43M	0.83%	15
2024 Q4	$5.4M	Buy	6,993 +3,054	+78%	+$2.53M	0.61%	32
2024 Q3	$3.49M	Buy	3,939 +1,859	+89%	+$1.67M	0.41%	60
2024 Q2	$1.88M	Buy	2,080 +27	+1%	+$21.6K	0.38%	59
2024 Q1	$1.6M	Buy	2,053 +371	+22%	+$264K	0.32%	70
2023 Q4	$980K	Sell	1,682 -35	-2%	-$20.4K	0.17%	74
2023 Q3	$922K	Buy	+1,717	New	+$885K	0.3%	75

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Norden Group's LLY Position: Q1 2026 in Review

Norden Group increased its Eli Lilly (LLY) stake by 2.7% in Q1 2026, buying an estimated $255K and bringing the position to 9,417 shares worth $8.66M. The position accounts for 0.83% of the portfolio, ranked #22.

Norden Group first reported a position in LLY in Q3 2023 and has held it in 11 quarters since. The position peaked at $9.85M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Norden Group held 9,417 shares of Eli Lilly worth $8.66M as of Q1 2026.
Norden Group bought 252 Eli Lilly shares in Q1 2026, an estimated $255K.
Eli Lilly made up 0.83% of Norden Group's portfolio in Q1 2026, its #22 holding.
Norden Group first reported a position in Eli Lilly in Q3 2023 and has held it in 11 quarters since.
Norden Group's Eli Lilly position peaked at $9.85M in Q4 2025.
4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Norden Group's 13F filing for Q1 2026, filed 15 Apr 2026.